Stage Analytics colleagues Bill Padula, Brett McQueen and Natalie Reid published an article in Health Affairs Forefront outlining how to reduce U.S. healthcare costs by leveraging available evidence to phase-out value defects.
Stage Analytics Principal Dr. Bill Padula was cited in a USA Today article exploring concerns that rates of pressure ulcer injury may escalate amidst the COVID-19 pandemic.
Stage Analytics Principal Dr. Bill Padula wrote a Health Affairs Blog exploring how economic evaluation methods can be used to determine the value and price of disruptive health technologies in a post-Covid-19 world.
Stage Analytics Principal Dr. Bill Padula co-authored a white paper which made a series of recommendations on Health Technology Assessments (HTA) in the United States.
Stage Analytics Co-Founder and Principal Dr. Caleb Alexander was prominently quoted discussing the U.S. opioid epidemic in an article in The Economist examining the role of pharmacies in contributing to harms.
Stage Analytics Co-Founder and Principal Dr. Caleb Alexander was quoted in an article in Nature examining the FDA's possible approval of an experimental Alzheimer's drug.
Stage Analytics Co-Founder and Principal Dr. Caleb Alexander was quoted in an article in The New York Times regarding the expansion of treatments for substance use disorders among pregnant women.
Stage Analytics Principal Dr. Bill Padula's scholarship was discussed in a Changing America article about adverse events in hospitals and health systems.